Avacta Share Discussion Threads

[toffeeman] 29/1/2020 13:18

Stig:

SNG has broken out of a long term downtrend similar to your AVCT chart.

[toffeeman] 29/1/2020 13:11

Finally in profit from Guinness Aim EIS investment at 25p!

[nordic1958] 29/1/2020 12:30

The biggest conference of the all, with Biotech Showcase and China Showcase all running in partnership with JPM.Very upbeat post conference statement from Avacta

[nordic1958] 29/1/2020 12:28

Yes what is important to remember is :Upbeat trading statement Bullish RNS Both JV licence deals with majors, involves fully funded R&D and marketing costs.In the case of Daewoong deal, Avacta retains the rights to commercialise the Affimer proteins outside of the field of cell therapies.Millions of dollars in R&D will be saved going forward!Also remember the very interesting deal the company made with ADC Therapeutics to develop breakthrough oncology treatments.Their license agreement with Moderna earlier in 2019.The majors will be lining up to talk to Avacta ref AVA6000.Significant re rating of the company is about to happen.AstraZeneca is major shareholder holder and partner with all Avacta's partners!!!

[smithie6] 29/1/2020 12:19

JPM conference ?

'recent' JP Morgan Medical Week ?

[nordic1958] 29/1/2020 12:01

Good to see we were right Been buying more since and during JPM conference.Read across valuation gives you a whole new number.

[someuwin] 29/1/2020 12:01

It's difficult to get you head around all the potential routes to commercialisation that AVCT have...

TWO novel platforms, Affimer(R) biotherapeutics and pre|CISION(TM). Their own new drug class, TMAC(TM) and its first drug AVA04-VbP (a better version of a Merck and Pfizer product).

Then there's the increasing list of big name pharma's who want to partner with AVCT to utilise their unique platforms...

"...Avacta has established drug development partnerships with pharma and biotech, including with Moderna Therapeutics Inc., a collaboration with LG Chem to develop treatments for autoimmune and inflammatory diseases worth up to $310m, a partnership with ADC Therapeutics to develop Affimer drug conjugates and a joint venture in South Korea with Daewoong Pharmaceuticals to develop the next generation of stem cell therapies that incorporate Affimer immuno-modulators. Avacta actively seeks to license its proprietary platforms in a range of therapeutic areas."

[the stigologist] 29/1/2020 11:54

Reminder of my post 2796

When Fundamentals, Technicals, Momentum and Newsflow all come together you have the ingredients for big moves in my experience

Check out the well defined long term downtrend line here. One more heave and we could see a serious breakout.

[someuwin] 29/1/2020 11:54

"The Affimer platform is an alternative to antibodies derived from a small human protein. Despite their shortcomings, antibodies currently dominate markets worth in excess of $100bn. Affimer technology has been designed to address many of these negative performance issues, principally: the time taken, and the reliance on an animal's immune response, to generate new antibodies; poor specificity in many cases; large size and cost."

[the stigologist] 29/1/2020 11:51

Breakaway gaps are powerful technical indicators themselves but we also have today a break above 200 day Moving Average also

To add to a double bottom and breakout of medium term downtrend line

Add fundamentals, newsflow and momentum and we are in an incredible moment here. I believe it could whoosh to 50-60 quite easily in coming weeks

[cheshire pete] 29/1/2020 11:51

Still time to top up escapetohome, indeed looking to do the same. Have been watching these for over 5 years from the protim days, mostly from the sidelines have to say. Feels different this time though.

[purple11] 29/1/2020 11:43

all fine and dandy gl

[nordic1958] 29/1/2020 11:20

Once 25 broken, new buyers coming in

[the stigologist] 29/1/2020 11:19

LOL normally I'd run away from Management being this promotional but i suspect they have good reason to be a bit giddy

[escapetohome] 29/1/2020 11:18

Very very nice.

Now own up - who sold at 15p or even less?

Not me, im a believer!!!!

Kicking myself for not topping up though!!!

[the stigologist] 29/1/2020 11:12

Melt up phase. Limited resistance now

[thesaint5] 29/1/2020 10:54

Excellent video explaining in simple terms yesterday's announcement, only a couple mins long, short and sweet -

[scotty1] 29/1/2020 10:12

Had a little lift today from this i would imagine,need a subscription to read all





Phew! My Priority Penny Share Tip Scorches Ahead on a Successful New Trial
BY MALCOLM STACEY

Hello Share People. It’s all looking chipper for medical pioneer Avacta (AVCT). When Tom interviewed me fairly recently for his scintillating radio podcast, I gave this company the dubious award as my favourite penny share. And so far, luckily, I am proving right. The latest news is pretty exciting and, as I write, has propelled the share up by 15%...

2 hours ago

[someuwin] 29/1/2020 10:06

A long way to go to get to finnCap's 76p target. (Which in itself will prove to be extremely conservative if things turn out remotely as well as we hope for)


free stock charts from uk.advfn.com

[cheshire pete] 29/1/2020 10:05

25p to buy now.

[thesaint5] 29/1/2020 09:46

Potentially further milestone payments with extended deal with LG -


"LG Chem has now expanded the collaboration by nominating the second and third drug targets and Avacta is beginning the discovery programmes for Affimer binders to those new targets. Each of these programmes also has the potential for further milestone payments."

[someuwin] 29/1/2020 09:26

Can't even buy 2k worth now.

[thesaint5] 29/1/2020 09:13

"Avacta has successfully generated a large number of Affimer proteins that bind to the first drug target nominated by LG Chem. These candidate Affimer molecules are now being optimised by Avacta, for LG Chem to then carry out pre-clinical development, successful completion of which would trigger the next substantial milestone payment to Avacta."

Are my thoughts correct that payment is due once molecules optimised by Avacta? The payment due ~$5.5 million plus costs?